Video Link: https://www.youtube.com/watch?v=3ORcFZPgrA0

Cancer Genetics: Implications of Risk Assessment for Risk Reduction
The first cancer susceptibility gene, Rb1, was cloned 25 years ago. Since then, numerous other cancer susceptibility genes have been identified, and clinical testing for many has been incorporated into clinical care. Epidemiologic assessments of cancer risks have led to the development of surveillance strategies. For the more common syndromes, there are ongoing trials assessing various modalities. For the rarer syndromes, recommendations are often extrapolations from existing data on more common conditions. Obtaining support for adequate clinic trials of surveillance and risk reduction strategies for rarer syndromes remain challenging. Understanding of susceptibility gene function should influence the design of intervention trials for risk reduction. The introduction of cancer genomics will clearly affect clinical cancer genetics going forward.From:CPRITTexasViews:0 0ratingsTime:32:22More inScience Technology

See more here:
Cancer Genetics: Implications of Risk Assessment for Risk Reduction - Video

Comments are closed.